Align Technology | ALGN - 贷款资金



金融业
股票价格
USD
资产
USD 6.31B
现金及等价物
USD 1.06B
销售成本
USD 303.5M
流动资产
USD 2.66B
流动负债
USD 1.91B
债务
USD 114.45M
EBIT
USD 178.05M
EBITDA
USD 260.87M
员工
20.95K
EPS每股收益
USD 2.58
股本和储备
USD 4.15B
销售毛利
USD 736.59M
债务利息支出
USD 16.05M
利息收入
USD 4.62M
贷款资金
USD 0
市值
USD 13.78B
净收入
USD 112.77M
营业费用
USD 862.03M
营业利润
USD 178.05M
普通股股本
USD 71.62M
PE价格收益
22.78
税前利润
USD 148.89M
销售收入
USD 1.04B
销售和管理费用
USD 465.34M
股票
USD 214.94M
贸易债权人
USD 123.72M
应收帐款人
USD 1.13B


贷款资金 更改 日
3M USD 10.91B 26M 2026-03
Align Technology USD 0 0 2024-12
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Bruker USD 1.66B 189.6M 2026-03
Cardinal Health USD 8.25B 102M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Cooper Companies USD 1.86B 17.7M 2026-03
CVS Health USD 60.53B 29M 2026-03
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.01B 9M 2026-03
Dexcom USD 1.3B 54.4M 2026-03
Henry Schein USD 2.33B 17M 2026-03
Idexx Laboratories USD 299.85M 74.99M 2026-03
Insulet USD 929.5M 1.3M 2026-03
Integra LifeSciences USD 1.83B 29.45M 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
McKesson USD 5.26B 166M 2026-03
Mettler Toledo International USD 2.16B 73.35M 2026-03
Revvity USD 2.63B 836K 2026-03
Solventum Corp USD 4.58B 460M 2026-03
Stryker USD 14.22B 635M 2026-03
Teleflex USD 2.51B 27.18M 2026-03
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Waters USD 5.22B 3.81B 2026-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03
Zoetis USD 9.04B 3M 2026-03